Green Cross Laboratory Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Green Cross Laboratory's estimated annual revenue is currently $6.9M per year.
- Green Cross Laboratory's estimated revenue per employee is $121,500
Employee Data
- Green Cross Laboratory has 57 Employees.
- Green Cross Laboratory grew their employee count by 19% last year.
Green Cross Laboratory Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.1M | 75 | 0% | N/A | N/A |
#2 | $3.5M | 32 | -9% | N/A | N/A |
#3 | $22.3M | 150 | -1% | N/A | N/A |
#4 | $6.9M | 57 | -2% | N/A | N/A |
#5 | $15.5M | 115 | -2% | N/A | N/A |
#6 | $14.6M | 108 | -22% | N/A | N/A |
#7 | $18.5M | 137 | -15% | N/A | N/A |
#8 | $6.3M | 52 | -27% | N/A | N/A |
#9 | $4.4M | 41 | -5% | N/A | N/A |
#10 | $197.2M | 1108 | 96% | $177M | N/A |
What Is Green Cross Laboratory?
check out the website
keywords:N/AN/A
Total Funding
57
Number of Employees
$6.9M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Green Cross Laboratory News
09/03/2019 - Las Cruces Utilities Opens New Lab to Refresh Water Quality ...
... the City's existing test site and is designed to meet green building ratings. Water Quality Lab Manager Luis Guerra has worked for the City for more than a ... which Guerra said helps prevent issues like cross-contamination.
09/08/2019 - Global Plasma Fractionation Market Growth opportunities ...
Clinical Research Laboratories ... China Biologic Products, Bio Prodcuts Laboratory (BPO), Japan Blood Products Organization, Green Cross ...
09/03/2019 - Malaysia Intravenous Immunoglobulin (IVIG) Market 2019 ...
KEY PLAYERS PROFILED. Grifols S.A.,. Octapharma AG. Green Cross Corporation. Baxalta (Shire). Bio Products Laboratory Ltd. Biotest AG,.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.1M | 57 | 30% | N/A |
#2 | $10.5M | 57 | -24% | N/A |
#3 | $11.3M | 57 | 19% | N/A |
#4 | $7.2M | 57 | 97% | N/A |
#5 | $6.4M | 57 | -62% | $122.8M |